StockData

Adagio Medical vs Pulse Biosciences

ADGM and PLSE side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ADGM and PLSE compare

Pulse Biosciences is the larger company, worth 2179 times as much as Adagio Medical ($3.2B against $1.5M).

Pulse Biosciences scores higher on the StockData Score (6 against 2 for Adagio Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricADGMPLSE
Size and price
Market cap$1.5M$3.2B
Share price$1.65$44.84
Change, 1 year110%211%
Change, 5 years−99.4%107%
Beta (5Y)–0.50
Employees41116
StockData Score
Total score26 (better)
Valuation score1 (better)0
Growth score00
Performance score1 (better)0
Health score06 (better)
Dividend score00
Valuation
P/S–2699×
P/B0.1× (better)32.1×
FCF yield−1203%−1.9% (better)
Profitability
Gross margin–0.25%
Operating margin–−7008%
Net margin–−6756%
FCF margin–−5180%
Return on equity9.6% (better)−78.5%
Return on invested capital−314%–
Financial health
Debt / equity–0.00
Interest coverage−5.8×–
Current ratio0.909.63 (better)
Altman Z-score−6.29111.94 (better)
Piotroski F-score–3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions–15.0%
Held by insiders–71.2%
Insider net buying, 12 months$244K$23.9M (better)
Short interest, % of float–14.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.